Ipsen ends 2021 deal spree with $543M biobucks tie-up for Genfit's liver disease drug | FierceBiotech

Retrieved on: 2021-12-17 15:45:48

Tags for this article:

Click the tags to see associated articles and topics

Ipsen ends 2021 deal spree with $543M biobucks tie-up for Genfit's liver disease drug | FierceBiotech. View article details on hiswai:

Excerpt

After a summer of deals, Ipsen is closing out the year with one last hurrah. The rare-disease-focused biopharma will partner with Genfit on a ...

Article found on: www.fiercebiotech.com